Table 6.
RESIDUAL AND RECURRENCE OF HCC AFTER DEFINITIVE TREATMENTS
| A Residual or Recurrent HCC Rates After Treatments | |||||
|---|---|---|---|---|---|
| Treatment Modality | No. Patients | Residual* HCC | Recurrence† at 1 Year | Recurrence at 3 Years | Recurrence at 5 Years |
| Liver transplantation | 50 | 10% | 0% | 6.4% | 8.6% |
| Liver resection | 52 | 19.2% | 9.9% | 31.7% | 47.9% |
| Radiofrequency ablation | 44 | 15.9% | 7.4% | 27.7% | 37.4% |
| Transarterial chemoembolization | 53 | 56.6% | 14.0% | 16.3% | 18.6% |
| *Residual: Enhancing lesions at the site of initial treatment within the first 6 months. | |||||
| †Recurrence: Free of HCC for 3‐6 months after initial treatment and then developed new intrahepatic lesions or extrahepatic metastases. | |||||
| B Comparison of Residual and Recurrence HCC Rates After Treatment | ||
|---|---|---|
| P Value for Residual HCC | P Value for Recurrent HCC | |
| LT vs. Resection | 0.19 | 0.0001 |
| LT vs. RFA | 0.39 | 0.0001 |
| LT vs. TACE | 0.0001 | 0.0863 |
| Resection vs. RFA | 0.67 | 0.9913 |
| Resection vs. TACE | 0.0001 | 0.0134 |
| RFA vs. TACE | 0.0001 | 0.0111 |